| __timestamp | Celldex Therapeutics, Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 1860000 |
| Thursday, January 1, 2015 | 33837000 | 2963000 |
| Friday, January 1, 2016 | 35979000 | 6961000 |
| Sunday, January 1, 2017 | 25003000 | 11779000 |
| Monday, January 1, 2018 | 19269000 | 13697000 |
| Tuesday, January 1, 2019 | 15426000 | 15749000 |
| Wednesday, January 1, 2020 | 14456000 | 18638000 |
| Friday, January 1, 2021 | 20488000 | 27196000 |
| Saturday, January 1, 2022 | 27195000 | 31739000 |
| Sunday, January 1, 2023 | 30914000 | 33491000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Protagonist Therapeutics, Inc. and Celldex Therapeutics, Inc. from 2014 to 2023. Over this period, Celldex consistently outspent Protagonist, with its SG&A expenses peaking in 2016 at approximately 36 million USD. In contrast, Protagonist's expenses showed a steady increase, reaching around 33 million USD by 2023, marking an impressive growth of over 1,700% from its 2014 figures. This trend highlights Protagonist's aggressive expansion strategy, while Celldex's fluctuating expenses suggest a more volatile approach. Understanding these financial dynamics offers valuable insights into each company's strategic priorities and market positioning.
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Celldex Therapeutics, Inc.
Who Optimizes SG&A Costs Better? GSK plc or Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing argenx SE and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of argenx SE and Celldex Therapeutics, Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Xenon Pharmaceuticals Inc. or Celldex Therapeutics, Inc.
Arrowhead Pharmaceuticals, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends